Efficacy of perioperative oral triiodothyronine replacement therapy in patients undergoing off-pump coronary artery bypass grafting

Yong Seon Choi, Jae Kwang Shim, Jong Wook Song, Young Song, So Young Yang, Younglan Kwak

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objective: The aim of this study was to assess the effects of oral triiodothyronine (T3) therapy on postoperative thyroid hormone concentrations, hemodynamic variables, and outcomes. Design: A prospective, randomized, controlled, double-blind study. Setting: Cardiac operating room at a single institution. Participants: One hundred patients undergoing elective off-pump coronary artery bypass graft surgery. Interventions: Patients received either 20 μg of oral T3 or placebo every 12 hours starting 20 minutes before anesthetic induction, for a total of 4 doses. Measurements and Main Results: Plasma concentrations of thyroid hormones were measured serially before surgery, upon arrival in the intensive care unit, and 12, 24, and 36 hours after surgery. Hemodynamic variables also were recorded serially. Postoperative inotrope requirement and major morbidity endpoints were assessed. Serum T3 concentrations were significantly higher with fewer patients having T3 concentrations below the normal range in the T3 group than the placebo group throughout the postoperative period. Hemodynamic variables, postoperative inotrope requirement, and outcome variables showed no differences between the groups. Conclusions: Oral T3 therapy significantly attenuated the postoperative decline in T3 concentrations in patients undergoing off-pump coronary artery bypass graft surgery. The lack of apparent clinical benefit merits further investigations in patients with reduced cardiac performance.

Original languageEnglish
Pages (from-to)1218-1223
Number of pages6
JournalJournal of Cardiothoracic and Vascular Anesthesia
Volume27
Issue number6
DOIs
Publication statusPublished - 2013 Dec 1

Fingerprint

Off-Pump Coronary Artery Bypass
Triiodothyronine
Coronary Artery Bypass
Hemodynamics
Thyroid Hormones
Placebos
Transplants
Therapeutics
Operating Rooms
Double-Blind Method
Postoperative Period
Intensive Care Units
Anesthetics
Reference Values
Morbidity
Serum

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine
  • Anesthesiology and Pain Medicine

Cite this

@article{f008b60aab584453a92491c08dbab681,
title = "Efficacy of perioperative oral triiodothyronine replacement therapy in patients undergoing off-pump coronary artery bypass grafting",
abstract = "Objective: The aim of this study was to assess the effects of oral triiodothyronine (T3) therapy on postoperative thyroid hormone concentrations, hemodynamic variables, and outcomes. Design: A prospective, randomized, controlled, double-blind study. Setting: Cardiac operating room at a single institution. Participants: One hundred patients undergoing elective off-pump coronary artery bypass graft surgery. Interventions: Patients received either 20 μg of oral T3 or placebo every 12 hours starting 20 minutes before anesthetic induction, for a total of 4 doses. Measurements and Main Results: Plasma concentrations of thyroid hormones were measured serially before surgery, upon arrival in the intensive care unit, and 12, 24, and 36 hours after surgery. Hemodynamic variables also were recorded serially. Postoperative inotrope requirement and major morbidity endpoints were assessed. Serum T3 concentrations were significantly higher with fewer patients having T3 concentrations below the normal range in the T3 group than the placebo group throughout the postoperative period. Hemodynamic variables, postoperative inotrope requirement, and outcome variables showed no differences between the groups. Conclusions: Oral T3 therapy significantly attenuated the postoperative decline in T3 concentrations in patients undergoing off-pump coronary artery bypass graft surgery. The lack of apparent clinical benefit merits further investigations in patients with reduced cardiac performance.",
author = "Choi, {Yong Seon} and Shim, {Jae Kwang} and Song, {Jong Wook} and Young Song and Yang, {So Young} and Younglan Kwak",
year = "2013",
month = "12",
day = "1",
doi = "10.1053/j.jvca.2013.01.027",
language = "English",
volume = "27",
pages = "1218--1223",
journal = "Journal of Cardiothoracic and Vascular Anesthesia",
issn = "1053-0770",
publisher = "W.B. Saunders Ltd",
number = "6",

}

Efficacy of perioperative oral triiodothyronine replacement therapy in patients undergoing off-pump coronary artery bypass grafting. / Choi, Yong Seon; Shim, Jae Kwang; Song, Jong Wook; Song, Young; Yang, So Young; Kwak, Younglan.

In: Journal of Cardiothoracic and Vascular Anesthesia, Vol. 27, No. 6, 01.12.2013, p. 1218-1223.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Efficacy of perioperative oral triiodothyronine replacement therapy in patients undergoing off-pump coronary artery bypass grafting

AU - Choi, Yong Seon

AU - Shim, Jae Kwang

AU - Song, Jong Wook

AU - Song, Young

AU - Yang, So Young

AU - Kwak, Younglan

PY - 2013/12/1

Y1 - 2013/12/1

N2 - Objective: The aim of this study was to assess the effects of oral triiodothyronine (T3) therapy on postoperative thyroid hormone concentrations, hemodynamic variables, and outcomes. Design: A prospective, randomized, controlled, double-blind study. Setting: Cardiac operating room at a single institution. Participants: One hundred patients undergoing elective off-pump coronary artery bypass graft surgery. Interventions: Patients received either 20 μg of oral T3 or placebo every 12 hours starting 20 minutes before anesthetic induction, for a total of 4 doses. Measurements and Main Results: Plasma concentrations of thyroid hormones were measured serially before surgery, upon arrival in the intensive care unit, and 12, 24, and 36 hours after surgery. Hemodynamic variables also were recorded serially. Postoperative inotrope requirement and major morbidity endpoints were assessed. Serum T3 concentrations were significantly higher with fewer patients having T3 concentrations below the normal range in the T3 group than the placebo group throughout the postoperative period. Hemodynamic variables, postoperative inotrope requirement, and outcome variables showed no differences between the groups. Conclusions: Oral T3 therapy significantly attenuated the postoperative decline in T3 concentrations in patients undergoing off-pump coronary artery bypass graft surgery. The lack of apparent clinical benefit merits further investigations in patients with reduced cardiac performance.

AB - Objective: The aim of this study was to assess the effects of oral triiodothyronine (T3) therapy on postoperative thyroid hormone concentrations, hemodynamic variables, and outcomes. Design: A prospective, randomized, controlled, double-blind study. Setting: Cardiac operating room at a single institution. Participants: One hundred patients undergoing elective off-pump coronary artery bypass graft surgery. Interventions: Patients received either 20 μg of oral T3 or placebo every 12 hours starting 20 minutes before anesthetic induction, for a total of 4 doses. Measurements and Main Results: Plasma concentrations of thyroid hormones were measured serially before surgery, upon arrival in the intensive care unit, and 12, 24, and 36 hours after surgery. Hemodynamic variables also were recorded serially. Postoperative inotrope requirement and major morbidity endpoints were assessed. Serum T3 concentrations were significantly higher with fewer patients having T3 concentrations below the normal range in the T3 group than the placebo group throughout the postoperative period. Hemodynamic variables, postoperative inotrope requirement, and outcome variables showed no differences between the groups. Conclusions: Oral T3 therapy significantly attenuated the postoperative decline in T3 concentrations in patients undergoing off-pump coronary artery bypass graft surgery. The lack of apparent clinical benefit merits further investigations in patients with reduced cardiac performance.

UR - http://www.scopus.com/inward/record.url?scp=84888302498&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888302498&partnerID=8YFLogxK

U2 - 10.1053/j.jvca.2013.01.027

DO - 10.1053/j.jvca.2013.01.027

M3 - Article

C2 - 23958074

AN - SCOPUS:84888302498

VL - 27

SP - 1218

EP - 1223

JO - Journal of Cardiothoracic and Vascular Anesthesia

JF - Journal of Cardiothoracic and Vascular Anesthesia

SN - 1053-0770

IS - 6

ER -